Pharma Icebreaker: Activity in ADCs, Appetite for Radioligands & Alignment for Business

Time: 8:00 am
day: Day One - AM

Details:

  • Discussing recent deal-making and current search and evaluation interests for context in the conference to follow
  • Sharing insights into decision-making, due diligence, and necessary data packages to more confidently bring information to networking conversations
  • Collectively hypothesizing future radioligand and ADC trends to present the buyer’s perspective on the potential of innovation in earlier development

Speakers:

Venky Raghavan Venky Raghavan leads Oncology Search and Evaluation at Novartis focused on solid tumors and is looking for partnership and M&A opportunities that can help bring Read more
Kalyan Chakravarthy
Steven Bartz Steven Bartz is Oncology S&E Team Lead at Pfizer.  The Pfizer Oncology S&E teams looks for opportunities to transact with companies that enable Pfizer to Read more
Adrianne Wong Adrianne Wong scouts for Oncology assets and innovative technology on behalf of Daiichi Sankyo Global Business Development to accelerate, optimize, and augment our ADC portfolio.  Dr. Wong builds cross-sector partnerships with Read more
Jenny Wang
Christopher Davies I am Business Development Project Leader (BDPL) in our Pharma Partnering (PP) organization based in South San Francisco. My job is to lead end to Read more
Natalia Ulyanova
He Tian
Andressa Smith Andressa Smith leads search & evaluation for J&J Innovative Medicine Oncology BD, focusing her efforts on transformational assets and ideas that will address the unmet Read more
Avnish Kapoor Avnish Kapoor leads Oncology business development activities at BMS focusing on sourcing innovation leveraging wide-range of MOAs across deal types ranging from licensing to M&A. Read more
Albert Hsia
Liat Izhak